PerkinElmer Inc. News
PerkinElmer Agrees to Buy Biolegend for $5.25 Billion
PerkinElmer agrees to buy BioLegend, a provider of antibodies and reagents, for about $5.25 billion in cash and stock.
Cramer's Mad Money Recap: Markets vs. Inflation
Jim Cramer analyzes the latest inflation data and looks at why the stock markets are still bullish.
Plug Power, Walgreens, 3D Systems: 5 Top Gainers for Thursday
Plug Power, Walgreens Boots, Oxford Immunotec, 3D Systems and Future FinTech are five top stock gainers for Thursday.
Stick With Stocks: Cramer's 'Mad Money' Recap (Thursday 11/5/20)
It used to be bonds vs. stocks, Jim Cramer says, but now the tables have turned.
Small Biz Woes: Cramer's 'Mad Money' Recap (Monday 8/17/20)
Jim Cramer says the big retailers are going to start gobbling up the smaller ones.
Breaking News
Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests
Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.
Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat
"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.
Stocks Higher, Bank Dividends, Nike, Playtika And Occidental- Five Things To Know
Stock futures higher on global growth bets; Morgan Stanley leads bank gains after dividend boost; Nike slides as margin pressures offset Q4 earnings beat; Playtika shares surge on report of Joffre Capital interest and Occidental shares jump as Buffett adds more to stake
Walgreens Stock Slides As Group Scraps Plan to Sell UK-based Boots
"As a result of market instability ... no third party has been able to make an offer that adequately reflects the high potential value of Boots," Walgreens said.